Literature DB >> 17397881

Substance P provides neuroprotection in cerebellar granule cells through Akt and MAPK/Erk activation: evidence for the involvement of the delayed rectifier potassium current.

G Amadoro1, M Pieri, M T Ciotti, I Carunchio, N Canu, P Calissano, C Zona, C Severini.   

Abstract

In the current study, we have evaluated the ability of substance P (SP) and other neurokinin 1 receptor (NK1) agonists to protect, in a dose- and time-dependent manner, primary cultures of rat cerebellar granule cells (CGCs) from serum and potassium deprivation-induced cell death (S-K5). We also established the presence of SP high affinity NK1 transcripts and the NK1 protein localization in the membrane of a sub-population of CGCs. Moreover, SP significantly and dose-dependently reduced the Akt 1/2 and Erk1/2 dephosphorylation induced by S-K5 conditions, as demonstrated by Western blot analysis. Surprisingly, in SP-treated CGCs caspase-3 activity was not inhibited, while the calpain-1 activity was moderately reduced. Corroborating this result, SP blocked calpain-mediated cleavage of tau protein, as demonstrated by the reduced appearance of a diagnostic fragment of 17 kDa by Western blot analysis. In addition, SP induced a significant reduction of the delayed rectifier K+ currents (Ik) in about 42% of the patched neurons, when these were evoked with depolarizing potential steps. Taken together, the present results demonstrate that the activation of NK1 receptors expressed in CGCs promote the neuronal survival via pathways involving Akt and Erk activation and by inhibition of Ik which can contribute to the neuroprotective effect of the peptide.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17397881     DOI: 10.1016/j.neuropharm.2007.01.020

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  18 in total

1.  The histone lysine demethylase Kdm6b is required for activity-dependent preconditioning of hippocampal neuronal survival.

Authors:  Ranjula Wijayatunge; Liang-Fu Chen; Young May Cha; Anthony S Zannas; Christopher L Frank; Anne E West
Journal:  Mol Cell Neurosci       Date:  2014-06-28       Impact factor: 4.314

2.  Peptidase neurolysin is an endogenous cerebroprotective mechanism in acute neurodegenerative disorders.

Authors:  Vardan T Karamyan
Journal:  Med Hypotheses       Date:  2019-07-13       Impact factor: 1.538

3.  Differential effects of aprepitant, a clinically used neurokinin-1 receptor antagonist on the expression of conditioned psychostimulant versus opioid reward.

Authors:  Padmanabhan Mannangatti; Santhanalakshmi Sundaramurthy; Sammanda Ramamoorthy; Lankupalle D Jayanthi
Journal:  Psychopharmacology (Berl)       Date:  2016-12-24       Impact factor: 4.530

Review 4.  The mammalian tachykinin ligand-receptor system: an emerging target for central neurological disorders.

Authors:  Nick Pantaleo; Wayne Chadwick; Sung-Soo Park; Liyun Wang; Yu Zhou; Bronwen Martin; Stuart Maudsley
Journal:  CNS Neurol Disord Drug Targets       Date:  2010-11       Impact factor: 4.388

5.  Intracellular emetic signaling cascades by which the selective neurokinin type 1 receptor (NK1R) agonist GR73632 evokes vomiting in the least shrew (Cryptotis parva).

Authors:  W Zhong; S Chebolu; N A Darmani
Journal:  Neurochem Int       Date:  2018-11-16       Impact factor: 3.921

6.  Apoptosis and in vitro Alzheimer disease neuronal models.

Authors:  P Calissano; C Matrone; G Amadoro
Journal:  Commun Integr Biol       Date:  2009

7.  A constitutively active form of neurokinin 1 receptor and neurokinin 1 receptor-mediated apoptosis in glioblastomas.

Authors:  Toshimasa Akazawa; Shawn G Kwatra; Laura E Goldsmith; Mark D Richardson; Elizabeth A Cox; John H Sampson; Madan M Kwatra
Journal:  J Neurochem       Date:  2009-03-11       Impact factor: 5.372

8.  Defects in the CAPN1 Gene Result in Alterations in Cerebellar Development and Cerebellar Ataxia in Mice and Humans.

Authors:  Yubin Wang; Joshua Hersheson; Dulce Lopez; Monia Hammer; Yan Liu; Ka-Hung Lee; Vanessa Pinto; Jeff Seinfeld; Sarah Wiethoff; Jiandong Sun; Rim Amouri; Faycal Hentati; Neema Baudry; Jennifer Tran; Andrew B Singleton; Marie Coutelier; Alexis Brice; Giovanni Stevanin; Alexandra Durr; Xiaoning Bi; Henry Houlden; Michel Baudry
Journal:  Cell Rep       Date:  2016-06-16       Impact factor: 9.423

9.  G-Protein Inwardly Rectifying Potassium Channel 1 (GIRK1) Knockdown Decreases Beta-Adrenergic, MAP Kinase and Akt Signaling in the MDA-MB-453 Breast Cancer Cell Line.

Authors:  Michael W Hance; Madhu S Dhar; Howard K Plummer
Journal:  Breast Cancer (Auckl)       Date:  2008-03-26

10.  Implicating calpain in tau-mediated toxicity in vivo.

Authors:  James B Reinecke; Sarah L DeVos; James P McGrath; Amanda M Shepard; Dustin K Goncharoff; Don N Tait; Samantha R Fleming; Michael P Vincent; Michelle L Steinhilb
Journal:  PLoS One       Date:  2011-08-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.